Autoimmune And Inflammation Lupus

Table of Contents

Lupus Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Lupus Projects
--Astion Pharma A/S
--Astellas Pharma Inc
--Biogen Idec Inc
--AstraZeneca Plc
--Galenica Ltd.
--Bristol-Myers Squibb Company
--Genentech Inc
--Genelabs Technologies Inc
--GlaxoSmithKline plc
--Genovate Biotechnology Co., Ltd.
--
--ImmuPharma plc
--Human Genome Sciences Inc
--Merck Serono S.A.
--La Jolla Pharmaceutical Co
--Teva Neuroscience
--Roche Holdings Ltd
--UCB S.A.
--Teva Pharmaceutical Industries Ltd
--ZymoGenetics Inc
--Watson Pharmaceuticals Inc

--Top Companies in early stage Lupus Projects
--Amgen Inc
--Active Biotech
--Argos Therapeutics, Inc.,
--erly Merix Bioscience)
--Anthera Pharmaceuticals, Inc.
--Biogen Idec Inc
--AstraZeneca Plc
--Chugai Pharma USA, LLC.
--ChemoCentryx, Inc.
--Farmacija d.o.o.
--Dynavax Technologies Corp
--Incyte Corporation
--Genentech Inc
--NEOVACS SA
--Medarex Inc
--SuppreMol GmbH
--Rigel Pharmaceuticals Inc
--UCB S.A.
--Tolerx, Inc.
--Wyeth
--Viron Therapeutics Inc

Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View